A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
Download in electronic PDF format for $75
Abstract: Most commercially available oral liquid preparations of ascorbic acid contain propylene glycol. At high doses, this common food and drug additive is know to increase the risk of serum hyperosmolality, with a marked osmolar gap, lactic acidosis, seizures, and cardiac arrhythmias. This is a particular danger in children. Concern about propylene glycol toxicity prompted the World Health Organization to establish a maximum daily dose of 25 mg/kg/day, but the toxic dose is not known. A stable ascorbic acid preparation can be formulated without propylene glycol. A formula and method are provided.
Related Keywords:
burns, burn units, vitamin C, children, propylene glycol, toxic effects, liquid formulations, adverse effects, ascorbic acid syrup, formulation: ascorbic acid 100-mg/mL syrup
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
McElhiney Linda F
|
Nov/Dec 2004
Pg. 458-460
|
Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 53
|
Ascorbic Acid 250-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 240
|
Ascorbic acid 5% Topical Microemulsion
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 423
|
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
Basics of Compounding for Cough
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 462-465
|
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 410
|
Kinetics of Tetracaine Solvolysis in Propylene Glycol
McPherson Timothy B, Neumann William L, Goolsby Michael, Kolling William M
|
Jul/Aug 2018
Pg. 329-334
|
L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers
Gorman Shellie
|
Mar/Apr 2000
Pg. 94-96
|
Ascorbic Acid 10% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 1998
Pg. 224
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Folic Acid 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 244
|
Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 65-67
|
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Zhang Yan-ping, Trissel Lawrence A
|
Mar/Apr 1997
Pg. 132-134
|
Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 58
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
May/Jun 2007
Pg. 220-225
|
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids
de Villiers Melgardt M, Narsai Kirti, van der Watt Jakkie G
|
Jan/Feb 2000
Pg. 72-75
|
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 386
|
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Zur Eyal
|
Mar/Apr 2012
Pg. 117-124
|
Compounding Pearls -- Wound Care: Burn Healing, Part 1
Riepl Mike
|
May/Jun 2020
Pg. 188-193
|
Return to Top |